{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:38:50Z","timestamp":1781941130774,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.clim.2012.11.012","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T08:46:09Z","timestamp":1355301969000},"page":"216-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Innate immune processes in lupus erythematosus"],"prefix":"10.1016","volume":"147","author":[{"given":"Martin","family":"Aringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ae","family":"Lee-Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2012.11.012_bb0435","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.24557","article-title":"Neutralization of interferon-alpha\/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus","volume":"60","author":"Yao","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0010","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0015","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0961203311426569","article-title":"Current state of evidence on \u201coff label\u201d therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria, and Switzerland \u2014 a consensus report","volume":"21","author":"Aringer","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2012.11.012_bb0025","first-page":"1558","article-title":"Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features","volume":"24","author":"Livneh","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2012.11.012_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002281-200301000-00011","article-title":"The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations","volume":"15","author":"Hull","year":"2003","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2012.11.012_bb0035","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2249.2011.04533.x","article-title":"Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1","volume":"167","author":"Goldbach-Mansky","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2012.11.012_bb0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-065X.2011.01046.x","article-title":"The inflammasome: an integrated view","volume":"243","author":"Gross","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2012.11.012_bb0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.11.012_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K","article-title":"Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus","volume":"46","author":"Baumann","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/art.21658","article-title":"Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation","volume":"54","author":"Kuhn","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0065","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.molimm.2009.04.029","article-title":"Complement in human diseases: lessons from complement deficiencies","volume":"46","author":"Botto","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2012.11.012_bb0070","first-page":"1768","article-title":"Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus","volume":"35","author":"Vlachoyiannopoulos","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2012.11.012_bb0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.22327","article-title":"Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus","volume":"56","author":"Aringer","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ng0598-3","article-title":"The lupus paradox","volume":"19","author":"Carroll","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.11.012_bb0440","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0961203309346508","article-title":"Complete complement deficiency in a large cohort of familial systemic lupus erythematosus","volume":"19","author":"Aggarwal","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2012.11.012_bb0445","first-page":"10","article-title":"Complement in the immunopathogenesis of rheumatic disease","author":"Sturfelt","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2012.11.012_bb0450","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/rheumatology\/39.2.133","article-title":"Links between complement abnormalities and systemic lupus erythematosus","volume":"39","author":"Pickering","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2012.11.012_bb0105","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J Exp. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2012.11.012_bb0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2012.11.012_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2012.11.012_bb0125","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ncprheum0292","article-title":"Mode of action of hydroxychloroquine in RA\u2014evidence of an inhibitory effect on Toll-like receptor signaling","volume":"2","author":"Kyburz","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.clim.2012.11.012_bb0130","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2012.11.012_bb0135","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines","volume":"186","author":"Kuznik","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.11.012_bb0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrg2571","article-title":"Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies","volume":"10","author":"Harley","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.clim.2012.11.012_bb0145","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0150","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20020207","article-title":"Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets","volume":"195","author":"Ito","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody\u2013DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2012.11.012_bb0160","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.4049\/jimmunol.1002821","article-title":"Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1\/4 kinase activity across human cell types","volume":"186","author":"Chiang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.11.012_bb0165","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1073\/pnas.0901181106","article-title":"Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus","volume":"106","author":"Jacob","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2012.11.012_bb0170","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature04641","article-title":"IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9","volume":"440","author":"Hoshino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.11.012_bb0175","doi-asserted-by":"crossref","first-page":"17005","DOI":"10.1074\/jbc.M412584200","article-title":"The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling","volume":"280","author":"Schoenemeyer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2012.11.012_bb0180","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.4049\/jimmunol.178.11.6876","article-title":"Murine dendritic cell type I IFN production induced by human IgG\u2013RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production","volume":"178","author":"Yasuda","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.11.012_bb0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/annrheumdis-2011-200463","article-title":"IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus","volume":"71","author":"Niewold","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2012.11.012_bb0190","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.11.012_bb0195","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri1957","article-title":"Toll-like receptors in systemic autoimmune disease","volume":"6","author":"Marshak-Rothstein","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2012.11.012_bb0455","article-title":"Therapeutic blockade of TNF in patients with SLE\u2014promising or crazy?","author":"Aringer","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2012.11.012_bb0510","article-title":"Human 6-sulfo LacNAc(slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus","author":"Hansel","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clim.2012.11.012_bb0215","first-page":"1473","article-title":"A bridge between interferon-alpha and tumor necrosis factor in lupus","volume":"35","author":"Aringer","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2012.11.012_bb0460","first-page":"10","article-title":"Large scale analysis of tumor necrosis factor alpha levels in systemic lupus erythematosus","author":"Weckerle","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0465","first-page":"10","article-title":"TNF-alpha blockade with infliximab in a patient with lupus erythematosus profundus","author":"Gunther","year":"2011","journal-title":"Acta Derm.Venereol."},{"key":"10.1016\/j.clim.2012.11.012_bb0230","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/rheumatology\/kep270","article-title":"Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients","volume":"48","author":"Aringer","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2012.11.012_bb0235","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/507848","article-title":"Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p","volume":"79","author":"Lee-Kirsch","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2012.11.012_bb0240","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513443","article-title":"Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi\u2013Goutieres syndrome","volume":"80","author":"Rice","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2012.11.012_bb0470","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00109-007-0199-9","article-title":"A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus","volume":"85","author":"Lee-Kirsch","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0250","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000222430","article-title":"Familial chilblain lupus\u2014a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1","volume":"219","author":"Gunther","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clim.2012.11.012_bb0255","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng.373","article-title":"Mutations involved in Aicardi\u2013Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response","volume":"41","author":"Rice","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.11.012_bb0475","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u2032\u20135\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.11.012_bb0265","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2012.11.012_bb0480","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","article-title":"Mutations in the gene encoding the 3\u2032\u20135\u2032 DNA exonuclease TREX1 cause Aicardi\u2013Goutieres syndrome at the AGS1 locus","volume":"38","author":"Crow","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.11.012_bb0275","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.27367","article-title":"Expanding the phenotypic spectrum of lupus erythematosus in Aicardi\u2013Goutieres syndrome","volume":"62","author":"Ramantani","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0280","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng1842","article-title":"Mutations in genes encoding ribonuclease H2 subunits cause Aicardi\u2013Goutieres syndrome and mimic congenital viral brain infection","volume":"38","author":"Crow","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.11.012_bb0285","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/art.27372","article-title":"Nucleic acid metabolism and systemic autoimmunity revisited","volume":"62","author":"Lee-Kirsch","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0290","doi-asserted-by":"crossref","first-page":"19655","DOI":"10.1074\/jbc.274.28.19655","article-title":"Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3\u2032\u21925\u2032 exonucleases","volume":"274","author":"Mazur","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2012.11.012_bb0295","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2007.10.017","article-title":"Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease","volume":"131","author":"Yang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.clim.2012.11.012_bb0300","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.clim.2012.11.012_bb0305","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nchembio.424","article-title":"Genome instability due to ribonucleotide incorporation into DNA","volume":"6","author":"Nick McElhinny","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.clim.2012.11.012_bb0310","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1074\/jbc.M109.059048","article-title":"The structure of the mammalian RNase H2 complex provides insight into RNA.DNA hybrid processing to prevent immune dysfunction","volume":"285","author":"Shaban","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2012.11.012_bb0315","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20120876","article-title":"Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity","author":"Hiller","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0320","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.cell.2012.04.011","article-title":"Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development","volume":"149","author":"Reijns","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.clim.2012.11.012_bb0325","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature10623","article-title":"HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase","volume":"480","author":"Goldstone","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.11.012_bb0330","doi-asserted-by":"crossref","first-page":"43596","DOI":"10.1074\/jbc.C111.317628","article-title":"Aicardi\u2013Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase","volume":"286","author":"Powell","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2012.11.012_bb0335","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ni.1941","article-title":"The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1","volume":"11","author":"Yan","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.11.012_bb0340","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2011.11.018","article-title":"Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease","volume":"36","author":"Gall","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2012.11.012_bb0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/cmi.2011.7","article-title":"Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists","volume":"8","author":"Nguyen-Pham","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2012.11.012_bb0350","doi-asserted-by":"crossref","first-page":"e22763","DOI":"10.1371\/journal.pone.0022763","article-title":"Interferon-alpha abrogates tolerance induction by human tolerogenic dendritic cells","volume":"6","author":"Bacher","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2012.11.012_bb0355","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2012.11.012_bb0485","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0365","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1002\/art.20798","article-title":"Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus","volume":"50","author":"Kirou","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0370","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.11.012_bb0375","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1191\/096120300674499064","article-title":"Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies","volume":"9","author":"Bengtsson","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2012.11.012_bb0380","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2012.11.012_bb0385","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2012.11.012_bb0490","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar2886","article-title":"Type I interferon in organ-targeted autoimmune and inflammatory diseases","volume":"12","author":"Crow","year":"2010","journal-title":"Arthritis Res.Ther."},{"key":"10.1016\/j.clim.2012.11.012_bb0395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/BOR.0b013e328010c547","article-title":"Syndromes and complications of interferon therapy","volume":"19","author":"Borg","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2012.11.012_bb0400","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.4049\/jimmunol.134.6.3868","article-title":"Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor","volume":"134","author":"Arend","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.11.012_bb0405","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/art.21892","volume":"54","author":"Mullazehi","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0410","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1191\/0961203304lu1047cr","article-title":"IL-1RA in refractory systemic lupus erythematosus","volume":"13","author":"Moosig","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2012.11.012_bb0495","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.2004.025858","article-title":"Preliminary results of safety and efficacy of the interleukin-1 receptor antagonist anakinra in patients with severe lupus arthritis","volume":"64","author":"Ostendorf","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"9 (Supplement)","key":"10.1016\/j.clim.2012.11.012_bb0500","first-page":"S526","article-title":"MEDI-545, an anti-interferon alpha monoclonal antibody, shows evidence of clinical activity in systemic lupus erythematosus","volume":"56","author":"Wallace","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2012.11.012_bb0430","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.clim.2012.11.012_bb0505","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661612002914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661612002914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T18:35:12Z","timestamp":1687890912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661612002914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1521661612002914"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2012.11.012","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate immune processes in lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2012.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}